Jacobs Levy Equity Management, Inc Ovid Therapeutics Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $21.8 Billion
- Q1 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 62,341 shares of OVID stock, worth $46,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,341
Previous 62,341
-0.0%
Holding current value
$46,755
Previous $200,000
5.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
43.2MCall Options Held
5.9KPut Options Held
300-
Eco R1 Capital, LLC San Francisco, CA6.12MShares$4.59 Million0.53% of portfolio
-
Rubric Capital Management LP New York, NY5.32MShares$3.99 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.2MShares$3.15 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.89 Million0.35% of portfolio
-
Madison Avenue Partners, LP New York, NY3.65MShares$2.74 Million2.22% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $52.8M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...